Mizuho Maintains Outperform on Inspire Medical Systems, Lowers Price Target to $70

Benzinga Newsdesk www.benzinga.com Negative 94.7%

Neg 94.7% Neu 0% Pos 0%

Mizuho analyst Anthony Petrone maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and lowers the price target from $85 to $70.